These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17611409)

  • 41. Recepteur d'Origine nantais (RON) tyrosine kinase splicing variants lacking exons 18 and 19 occur ubiquitously in lung cancer.
    Krishnaswamy S; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
    Int J Clin Exp Med; 2015; 8(11):20778-86. PubMed ID: 26885001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing.
    Krishnaswamy S; Mohammed AK; Tripathi G; Alokail MS; Al-Daghri NM
    BMC Cancer; 2017 Nov; 17(1):738. PubMed ID: 29121914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility.
    Zhang K; Yao HP; Wang MH
    Carcinogenesis; 2008 Mar; 29(3):552-9. PubMed ID: 18204077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
    Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
    Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
    Johnson AL; Zinser GM; Waltz SE
    Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities.
    Wang MH; Zhou YQ; Chen YQ
    Scand J Immunol; 2002 Dec; 56(6):545-53. PubMed ID: 12472665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells.
    Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE
    Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of the RON receptor tyrosine kinase expression in macrophages: blocking the RON gene transcription by endotoxin-induced nitric oxide.
    Wang MH; Fung HL; Chen YQ
    J Immunol; 2000 Apr; 164(7):3815-21. PubMed ID: 10725742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor.
    Santoro MM; Penengo L; Minetto M; Orecchia S; Cilli M; Gaudino G
    Oncogene; 1998 Aug; 17(6):741-9. PubMed ID: 9715276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression.
    Bardella C; Costa B; Maggiora P; Patane' S; Olivero M; Ranzani GN; De Bortoli M; Comoglio PM; Di Renzo MF
    Cancer Res; 2004 Aug; 64(15):5154-61. PubMed ID: 15289319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression.
    Chen YQ; Fisher JH; Wang MH
    J Immunol; 1998 Nov; 161(9):4950-9. PubMed ID: 9794431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RONΔ160/PI3K/AKT signaling pathway activation.
    Yu S; Chen C; Chen M; Liang J; Jiang K; Lou B; Lu J; Zhu X; Zhou D
    J Exp Clin Cancer Res; 2024 Jan; 43(1):32. PubMed ID: 38268030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses.
    Waltz SE; Eaton L; Toney-Earley K; Hess KA; Peace BE; Ihlendorf JR; Wang MH; Kaestner KH; Degen SJ
    J Clin Invest; 2001 Aug; 108(4):567-76. PubMed ID: 11518730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RON alternative splicing regulation in primary ovarian cancer.
    Mayer S; Hirschfeld M; Jaeger M; Pies S; Iborra S; Erbes T; Stickeler E
    Oncol Rep; 2015 Jul; 34(1):423-30. PubMed ID: 25997828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor.
    Peace BE; Hill KJ; Degen SJ; Waltz SE
    Exp Cell Res; 2003 Oct; 289(2):317-25. PubMed ID: 14499632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
    Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
    Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transformation and scattering activities of the receptor tyrosine kinase RON/Stk in rodent fibroblasts and lack of regulation by the jaagsiekte sheep retrovirus receptor, Hyal2.
    Miller AD; Van Hoeven NS; Liu SL
    BMC Cancer; 2004 Sep; 4():64. PubMed ID: 15363108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteolytic activation of pro-macrophage-stimulating protein by hepsin.
    Ganesan R; Kolumam GA; Lin SJ; Xie MH; Santell L; Wu TD; Lazarus RA; Chaudhuri A; Kirchhofer D
    Mol Cancer Res; 2011 Sep; 9(9):1175-86. PubMed ID: 21875933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ron tyrosine kinase receptor regulates papilloma growth and malignant conversion in a murine model of skin carcinogenesis.
    Chan EL; Peace BE; Collins MH; Toney-Earley K; Waltz SE
    Oncogene; 2005 Jan; 24(3):479-88. PubMed ID: 15531916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein.
    Wang MH; Montero-Julian FA; Dauny I; Leonard EJ
    Oncogene; 1996 Nov; 13(10):2167-75. PubMed ID: 8950984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.